Stimuliver
Company Details
Status: Private
Employees: 1-10
Location:
copenhagen, capital region of denmark, denmark
Type:
sample
sample
Technology:
sample
sample
About: Liver disease kills approximately two million people per annum. Although organ transplant is a viable option to treat disease, many patients are not candidates for this type of treatment or die on the transplant waiting list.
Stimuliver is developing a disruptive liver implant to treat critically failing liver function in humans.
The implant will be placed underneath the skin to ‘top up' the patient's reduced liver function. Lab engineered liver tissue will be produced from human stem cells, providing a scalable and renewable source of human liver tissue. The development of the liver implant to clinical grade will provide patients with a renewable treatment option for their disease.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Stimuliver | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.